Navigation Links
Oclaro Reports Positive Adjusted EBITDA in First Post-Merger Quarter
Date:7/23/2009

ion from or as a substitute for financial information presented in accordance with generally accepted accounting principles, and may be different from non-GAAP measures used by other companies. The GAAP measure most directly comparable to non-GAAP revenues is revenues. The GAAP measure most directly comparable to non-GAAP net income/loss is net income/loss. The GAAP measure most directly comparable to Adjusted EBITDA is net income/loss. The GAAP measure most directly comparable to non-GAAP gross margin rate is gross margin rate. An explanation and reconciliation of each of these non-GAAP financial measures to GAAP information is set forth below.

Non-GAAP Revenues

Non-GAAP revenues include the revenues of New Focus, which is treated as a discontinued operation in our GAAP financial statements. Management uses this non-GAAP measure to evaluate its performance relative to its previously established financial targets. Specifically, the Company previously reported New Focus in its revenues and provided guidance for the fourth quarter of fiscal 2009 which included the New Focus business. The Company believes providing non-GAAP revenues to its investors, in addition to corresponding income statement measures, allows investors to evaluate the Company's results of operations compared to its previous financial results and previously provided guidance for the fourth quarter of fiscal 2009.

Non-GAAP Net Income/Loss

Non-GAAP net income/loss is calculated as net income/loss excluding the impact of restructuring and severance costs, non-cash compensation related to stock and options granted to employees and directors, income taxes, impairment charges and certain other one-time charges and credits specifically identified in the non-GAAP reconciliation schedules set forth below. The Company uses non-GAAP net income/loss in evaluating the Company's historical and prospective operating financia
'/>"/>

SOURCE Oclaro, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. Oclaro Launches Eye-Safe High Power Laser Diodes at LASER 2009
2. Hard to Treat Diseases, Inc. (HTDS) Reports on Ribavirin Research as Potential Treatment for MS
3. Zimmer Holdings, Inc. Reports Second Quarter 2009 Financial Results
4. Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance
5. Digirad Corporation Reports Second Quarter 2009 Financial Results
6. Affymetrix Reports Second Quarter 2009 Results
7. Exponent Reports Second Quarter 2009 Results
8. Endologix Reports 42% Second Quarter 2009 Revenue Growth
9. Universal Health Realty Income Trust Reports 2009 Second Quarter Financial Results
10. Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance
11. Amylin Pharmaceuticals Reports Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , ... July 07, 2015 , ... America is blessed ... California Casualty’s Nominate A Hero program offers a special way to say “thanks.” ... hero receives a $250 gift card and their place on the “Wall of Heroes.” ...
(Date:7/7/2015)... AURORA, Colo. (PRWEB) , ... ... ... healthcare landscape relies on highly educated and motivated leaders with strong managerial ... how well they clearly communicate with patients, staff, providers, business partners, insurance ...
(Date:7/7/2015)... Toronto, ON (PRWEB) , ... July 07, 2015 , ... ... which is effective immediately and permits the use of gluten-free claims for gluten free ... the prospect of expanding the Gluten-Free Certification Program (GFCP) to include gluten-free ...
(Date:7/7/2015)... ... July 07, 2015 , ... CSG ... have been selected by the Department of Vermont Health Access to provide Quality ... Information System (MMIS) and Integrated Contact Center System project. , Vermont is implementing ...
(Date:7/6/2015)... , ... July 06, 2015 , ... ... pre-clinical stages of drug discovery. iPSCs are generated from adult cells, such as ... any cell type in the human body. , iPSC-derived cardiomyocytes ...
Breaking Medicine News(10 mins):Health News:California Casualty Wants to Know: "Who Is Your Hero?" 2Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 2Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 3Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 4Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 2Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 3Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 4Health News:CSG Government Solutions Selected by the Department of Vermont Health Access to Provide Quality Assurance and Independent Verification and Validation Services 2Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 2Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 4
... the damage to their lungs that exacerbates asthmatic symptoms just ... the University of Groningen in the Netherlands. The ... American Thoracic Society,s American Journal of Respiratory and Critical ... smoke appears to increase the thickness of the epithelium, or ...
... become a mainstay of multiple myeloma treatment may outperform ... who have received stem cell transplants from unrelated, partially ... be presented by Dana-Farber Cancer Institute investigators ... on Sunday, Dec. 6 (Abstract 48, Ernest N. Morial ...
... College of Wisconsin, in Milwaukee, found a substantial variation ... disease complications in children. Barriers to its use on ... identified. The study led by Amanda M. Brandow, ... College and Children,s Research Institute at the Children,s Hospital ...
... Hamilton, ON. Dec. 6, 2009 A new study provides ... as venous thromboembolism (VTE). The condition is estimated ... occurs when an abnormal clot forms in a vein and ... some cases, the clot may detach from its point of ...
... NEW ORLEANSA new three-drug combination has shown in a phase ... regimen" in the treatment of patients newly diagnosed with multiple ... say researchers from Dana-Farber Cancer Institute. Partial responses or ... with the drug combination in the multi-center study, with 74 ...
... , --In Youngest ... , PHILADELPHIA and NEW ORLEANS, Dec. 5 Pediatric ... with another gene to drive an often-fatal form of leukemia ... expect to better predict which infants may benefit from particular ...
Cached Medicine News:Health News:Quitting smoking can reverse asthma-inducing changes in lungs 2Health News:Bortezomib shows promise in reducing GVHD and reconstituting immune system in some patients 2Health News:New study finds barriers to pain treatment in children with sickle cell disease 2Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4
(Date:7/6/2015)...  OrthoSpace Ltd. ("OrthoSpace" or "Company") announced today ... its US Investigational Device Exemption (IDE) pivotal study.  ... blinded control study that compares the Company,s InSpace ... repair for the treatment of full thickness massive ... available outside of the United States ...
(Date:7/6/2015)... , July 6, 2015 /CNW/ - The Canadian Pharmacists Association ... immunization strategy to ensure that all Canadians have the ... HPV (human papillomavirus) through immunization. The lack of access ... Canada is needlessly putting the health ... such as HPV, continue to pose a significant threat ...
(Date:7/6/2015)... 6, 2015 Mauna Kea ... multidisciplinary confocal laser endomicroscopy platform, announced today it ... Ministry of Health, Labor and Welfare (MHLW) ... the AQ-Flex 19 miniprobe.   Used ... miniprobe is comprised of a fiber-optic microscope that ...
Breaking Medicine Technology:OrthoSpace Enrolls First Patients in US IDE Study 2CPhA Calls for HPV Strategy for Young Men to Save Lives 2Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 2Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: